174 related articles for article (PubMed ID: 2306268)
1. Inhibition of acyl coenzyme A: cholesterol acyl transferase by trimethylcyclohexanylmandelate (cyclandelate).
Heffron F; Middleton B; White DA
Biochem Pharmacol; 1990 Feb; 39(3):575-80. PubMed ID: 2306268
[TBL] [Abstract][Full Text] [Related]
2. The effects of two acylcoenzyme A: cholesterol acyltransferase (ACAT) inhibitors, cyclandelate and a non-hydrolysable ether analogue, benzyl3,3,5-trimethylcyclohexanol on low density lipoprotein metabolism in macrophages and hepatocytes.
White DA; Heffron F; Knight D; Salter AM
Biochem Pharmacol; 1994 Aug; 48(5):915-22. PubMed ID: 8093104
[TBL] [Abstract][Full Text] [Related]
3. Cyclandelate. An inhibitor of cholesterol esterification.
Middleton B; Cacciaguerra F; White D
Drugs; 1987; 33 Suppl 2():75-9. PubMed ID: 3622309
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of cholesterol esterification by cyclandelate in transformed mouse macrophages.
Heffron F; Middleton B; White DA
Biochem Pharmacol; 1993 May; 45(9):1829-34. PubMed ID: 8494541
[TBL] [Abstract][Full Text] [Related]
5. Studies on acyl-CoA: cholesterol acyltransferase (ACAT) inhibitory effects and enzyme selectivity of F-1394, a pantotheic acid derivative.
Kusunoki J; Aragane K; Yamaura T; Ohnishi H
Jpn J Pharmacol; 1995 Mar; 67(3):195-203. PubMed ID: 7630037
[TBL] [Abstract][Full Text] [Related]
6. In vivo inhibition of hepatic lipogenesis in the rat by cyclandelate (3,3',5-trimethylcyclohexanylmandelate).
Middleton A; White DA; Bell GD; Middleton B
Biochem Pharmacol; 1983 Oct; 32(20):3079-83. PubMed ID: 6639676
[TBL] [Abstract][Full Text] [Related]
7. Microsomal long chain fatty acyl-CoA transacylation: differential effect of sterol carrier protein-2.
Chao H; Billheimer JT; Kier AB; Schroeder F
Biochim Biophys Acta; 1999 Aug; 1439(3):371-83. PubMed ID: 10498408
[TBL] [Abstract][Full Text] [Related]
8. Acyl-CoA binding protein (ACBP) regulates acyl-CoA:cholesterol acyltransferase (ACAT) in human mononuclear phagocytes.
Kerkhoff C; Beuck M; Threige-Rasmussen J; Spener F; Knudsen J; Schmitz G
Biochim Biophys Acta; 1997 Jun; 1346(2):163-72. PubMed ID: 9219899
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
10. Effect of membrane environment on inhibition of acyl-CoA:cholesterol acyltransferase by a range of synthetic inhibitors.
Harte RA; Yeaman SJ; Jackson B; Suckling KE
Biochim Biophys Acta; 1995 Oct; 1258(3):241-50. PubMed ID: 7548193
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and of acyl coenzyme A:cholesterol acyltransferase by dietary fat.
Mitropoulos KA; Venkatesan S; Balasubramaniam S
Biochim Biophys Acta; 1980 Aug; 619(2):247-57. PubMed ID: 7407210
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of acyl coenzyme A: cholesterol acyltransferase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Ishida F; Sato A; Iizuka Y; Kamei T
Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1635-6. PubMed ID: 2776246
[TBL] [Abstract][Full Text] [Related]
13. Rat liver acyl-coenzyme A:cholesterol acyltransferase: its regulation in vivo and some of its properties in vitro.
Erickson SK; Shrewsbury MA; Brooks C; Meyer DJ
J Lipid Res; 1980 Sep; 21(7):930-41. PubMed ID: 7441061
[TBL] [Abstract][Full Text] [Related]
14. Rabbit and human liver contain a novel pentacyclic triterpene ester with acyl-CoA: cholesterol acyltransferase inhibitory activity.
Tabas I; Chen LL; Clader JW; McPhail AT; Burnett DA; Bartner P; Das PR; Pramanik BN; Puar MS; Feinmark SJ
J Biol Chem; 1990 May; 265(14):8042-51. PubMed ID: 2335515
[TBL] [Abstract][Full Text] [Related]
15. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
[TBL] [Abstract][Full Text] [Related]
16. Chemical modification of acyl-CoA:cholesterol O-acyltransferase. 2. Identification of a coenzyme A regulatory site by p-mercuribenzoate modification.
Kinnunen PM; Spilburg CA; Lange LG
Biochemistry; 1988 Sep; 27(19):7351-6. PubMed ID: 3207681
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and structure--activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
Maduskuie TP; Wilde RG; Billheimer JT; Cromley DA; Germain S; Gillies PJ; Higley CA; Johnson AL; Pennev P; Shimshick EJ
J Med Chem; 1995 Mar; 38(7):1067-83. PubMed ID: 7707310
[TBL] [Abstract][Full Text] [Related]
18. Evidence against a role for phosphorylation/dephosphorylation in the regulation of acyl-CoA:cholesterol acyl transferase.
Corton JM; Hardie DG
Eur J Biochem; 1992 Feb; 204(1):203-8. PubMed ID: 1310941
[TBL] [Abstract][Full Text] [Related]
19. Regulation of acylcoenzyme A. Cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by lipoproteins in the intestine of parabiont rats.
Purdy BH; Field FJ
J Clin Invest; 1984 Aug; 74(2):351-7. PubMed ID: 6746898
[TBL] [Abstract][Full Text] [Related]
20. Chemical modification of acyl-CoA:cholesterol O-acyltransferase. 1. Identification of acyl-CoA:cholesterol O-acyltransferase subtypes by differential diethyl pyrocarbonate sensitivity.
Kinnunen PM; DeMichele A; Lange LG
Biochemistry; 1988 Sep; 27(19):7344-50. PubMed ID: 3207680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
